studi
investig
longterm
excret
sever
acut
respiratori
syndromeassoci
coronaviru
sputum
stool
specimen
infect
patient
median
rang
durat
viru
excret
sputa
stool
day
respect
coexist
ill
condit
associ
longer
viral
excret
stool
studi
investig
longterm
excret
sever
acut
respiratori
syndromeassoci
coronaviru
sputum
stool
specimen
infect
patient
median
rang
durat
viru
excret
sputa
stool
day
respect
coexist
ill
condit
associ
longer
viral
excret
stool
ever
acut
respiratori
syndrom
sar
newli
emerg
diseas
spread
global
earli
case
death
occur
beij
china
initi
outbreak
period
diagnosi
infect
mostli
depend
clinic
manifest
epidemiolog
find
associ
coronaviru
sarscov
identifi
causal
agent
immedi
full
genom
sequenc
molecular
assay
use
revers
transcriptasepolymeras
chain
reaction
rtpcr
develop
import
diagnost
tool
varieti
clinic
sampl
sever
studi
explor
optim
sourc
time
sampl
collect
sar
diagnosi
basi
rtpcr
result
viral
genet
materi
could
detect
rtpcr
stool
day
viru
could
cultur
week
ill
correspond
specimen
although
longterm
viral
excret
import
public
health
implic
potenti
spread
viru
environ
studi
yet
explor
factor
associ
prolong
viral
excret
risk
transmiss
household
contact
studi
design
investig
prospect
viral
shed
cohort
beij
sar
patient
month
clinic
epidemiolog
data
use
identifi
potenti
risk
factor
prolong
viru
shed
household
contact
sar
patient
clinic
monitor
secondari
transmiss
patient
recruit
studi
one
design
hospit
sar
patient
beij
diagnosi
probabl
sar
made
accord
definit
promulg
world
health
organ
briefli
case
definit
includ
follow
fever
cough
short
breath
new
pulmonari
infiltr
chest
radiographi
histori
exposur
patient
sar
absenc
respons
empir
antimicrobi
therapi
typic
atyp
pneumonia
stool
sputum
specimen
probabl
sar
patient
collect
weekli
hospit
monthli
discharg
month
onset
diseas
specimen
transport
viral
transport
medium
store
test
inform
consent
obtain
epidemiolog
clinic
data
collect
studi
particip
use
standard
data
collect
form
interview
medic
record
review
obtain
inform
includ
follow
item
age
sex
occup
medic
histori
time
natur
exposur
symptom
physic
find
laboratori
test
admiss
hospit
outcom
discharg
questionnair
also
use
identifi
suspect
probabl
sar
case
among
household
contact
sar
patient
discharg
questionnair
administ
month
discharg
hospit
end
followup
period
specimen
analyz
rtpcr
protocol
optim
laboratori
earli
sampl
patient
test
patient
least
one
sampl
test
posit
sarscov
rna
first
day
kept
studi
subsequ
sampl
patient
test
three
consecut
sampl
neg
first
neg
sampl
defin
time
negativ
rna
clinic
sampl
extract
use
qiaamp
viru
rna
mini
kit
qiagen
hilden
germani
instruct
manufactur
total
rna
revers
transcrib
random
hexam
cdna
amplifi
two
primer
pair
first
pair
one
primer
pair
recommend
world
health
organ
http
wwwwhointcsrsarsprimersen
second
pair
design
amplifi
fragment
replicas
gene
agg
tta
gct
aac
gag
tgt
gcg
ctg
tgt
tgt
aga
ttg
cgg
two
primer
pair
select
among
other
includ
higher
sensit
respect
use
serolog
test
standard
congruenc
result
two
test
f
tang
per
comm
specimen
posit
result
primer
pair
consid
posit
falseposit
result
elimin
procedur
posit
neg
control
systemat
includ
treat
way
viru
sampl
viral
isol
perform
rtpcrposit
stool
sampl
convalesc
patient
sampl
pretreat
centrifug
supernat
inject
filtrat
cell
cultur
procedur
handl
biosafeti
level
condit
look
characterist
cytopath
effect
day
inject
examin
electron
microscop
rtpcr
assay
use
identif
sarscov
data
process
spss
spss
inc
chicago
il
stata
stata
corpor
colleg
station
tx
softwar
categor
continu
variabl
compar
across
studi
group
mean
fisher
exact
test
mannwhitney
u
test
appropri
surviv
analysi
perform
use
time
rtpcr
negativ
outcom
variabl
stool
sputum
specimen
separ
surviv
curv
built
use
kaplanmei
method
correl
coeffici
time
rtpcr
negativ
stool
sputum
calcul
use
spearman
rank
correl
coeffici
midmarch
earli
may
total
probabl
sar
patient
admit
beij
hospit
dedic
sar
patient
least
one
rtpcrposit
sampl
first
day
hospit
therefor
enrol
studi
studi
group
consist
male
femal
particip
median
age
year
respect
patient
healthcar
worker
median
rang
durat
onset
symptom
hospit
day
median
rang
durat
hospit
stay
day
six
patient
coexist
medic
condit
ill
enrol
followup
diabet
patient
heart
diseas
patient
pulmonari
tuberculosi
patient
includ
diabet
high
blood
pressur
patient
patient
die
total
stool
sputum
specimen
collect
patient
studi
period
median
rang
durat
onset
symptom
first
posit
rtpcr
test
result
day
stool
day
sputum
rtpcr
sputum
stool
specimen
show
neg
result
day
day
diseas
onset
respect
figur
median
rang
durat
viral
excret
day
sputum
sampl
day
stool
specimen
neg
rtpcr
result
occur
time
sputum
stool
sampl
patient
later
time
stool
sampl
sputum
patient
spearman
rank
correl
coeffici
time
rtpcr
negativ
sputum
stool
p
four
patient
viral
excret
stool
day
three
patient
coexist
condit
pulmonari
tuberculosi
patient
diabet
patient
also
tuberculosi
high
blood
pressur
patient
proport
patient
coexist
condit
significantli
higher
patient
viral
excret
day
compar
other
vs
p
fisher
exact
test
attempt
n
isol
viru
rtpcrposit
stool
specimen
collect
week
diseas
onset
fail
patient
least
one
close
contact
clinic
symptom
suggest
sar
develop
close
contact
convalesc
sar
patient
survey
studi
first
document
durat
sarscov
excret
sputum
stool
cohort
sar
patient
median
durat
viral
excret
week
sputa
week
stool
sampl
estim
might
high
sinc
patient
short
viral
excret
might
miss
studi
design
patient
durat
viral
excret
specimen
ident
longer
stool
sampl
compar
sputa
patient
long
durat
excret
day
onset
symptom
observ
stool
four
patient
suggest
independ
replic
viru
may
take
place
intestin
tract
three
four
patient
coexist
condit
known
risk
factor
prolong
sar
ill
prolong
viral
excret
may
import
public
health
implic
respons
spread
viru
person
environ
two
find
studi
reassur
regard
one
failur
attempt
isol
viru
posit
rtpcr
specimen
collect
convalesc
patient
suggest
excret
viru
longer
infecti
absenc
sar
close
contact
convalesc
patient
studi
period
studi
demonstr
longterm
durat
sarscov
excret
stool
care
hand
toilet
disinfect
requir
avoid
transmiss
viru
close
contact
patient
